CD248 and sarcoma: O'Shannessy et al. examined endosialin expression in a cohort of 94 sarcoma patients and found that endosialin was highly expressed and that its expression was positively correlated with the expression level of platelet-derived growth factor receptor-β (PDGFR-β) 33.